September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Association between Increased Vascular Density and Loss of Protective RAS in Early-Stage NPDR
Author Affiliations & Notes
  • Krishnan Radhakrishnan
    Clinical Epidemiology Research Center, CT Healthcare System, U.S. Department of Veterans Affairs, West Haven, Connecticut, United States
    Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, United States
  • Sneha Raghunandan
    Space Life Sciences Research Branch, NASA Ames Research Center, Moffett Field, California, United States
  • Ruchi J Vyas
    Space Life Sciences Research Branch, NASA Ames Research Center, Moffett Field, California, United States
  • Amanda C. Vu
    NASA SLSTP Summer Internship Program/ Department of Biomedical Engineering, University of Berkeley, Berkeley, California, United States
  • Douglas Bryant
    Department of Ophthalmology, The Eugene and Marilyn Glick Eye Institute, Indiana University, Indianapolis, Indiana, United States
  • Yaqian Duan
    Department of Ophthalmology, The Eugene and Marilyn Glick Eye Institute, Indiana University, Indianapolis, Indiana, United States
  • Brenda E. Knecht
    Department of Ophthalmology, The Eugene and Marilyn Glick Eye Institute, Indiana University, Indianapolis, Indiana, United States
  • KV Chalam
    Department of Ophthalmology, University of Florida, Jacksonville, Florida, United States
  • Maria B Grant
    Department of Ophthalmology, The Eugene and Marilyn Glick Eye Institute, Indiana University, Indianapolis, Indiana, United States
    Department of Integrative and Cellular Physiology, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Patricia A Parsons-Wingerter
    Space Life Sciences Research Branch, NASA Ames Research Center, Moffett Field, California, United States
  • Footnotes
    Commercial Relationships   Krishnan Radhakrishnan, None; Sneha Raghunandan, None; Ruchi Vyas, None; Amanda C. Vu, None; Douglas Bryant, None; Yaqian Duan, None; Brenda E. Knecht, None; KV Chalam, None; Maria Grant, None; Patricia Parsons-Wingerter, None
  • Footnotes
    Support  NHLBI R01HL110170 to M Grant and P Parsons. NASA Human Research Program to P Parsons.
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 5035. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Krishnan Radhakrishnan, Sneha Raghunandan, Ruchi J Vyas, Amanda C. Vu, Douglas Bryant, Yaqian Duan, Brenda E. Knecht, KV Chalam, Maria B Grant, Patricia A Parsons-Wingerter; Association between Increased Vascular Density and Loss of Protective RAS in Early-Stage NPDR. Invest. Ophthalmol. Vis. Sci. 2016;57(12):5035.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Our hypothesis predicts that retinal blood vessels increase in density during early-stage progression to moderate nonproliferative diabetic retinopathy (NPDR). The renin-angiotensin system (RAS) is implicated in the pathogenesis of DR and in the function of circulating angiogenic cells (CACs), a critical bone marrow-derived population that is instrumental in vascular repair.

Methods : Arterial and venous patterns extracted from images of 6 normal controls and 3 early NPDR subjects (2 moderate, 1 mild) by Spectralis® OCT following fluorescein angiography (FA) were mapped by NASA’s VESsel GENeration Analysis (VESGEN) software to yield branching generations (Gx) quantified by parameters that include densities of vessel length (Lv), area (Av) and number (Nv). Peripheral blood of diabetics and controls was collected for CD34+ CAC isolation. RAS gene expressions in CACs were measured by qPCR for Mas receptor for Ang-(1-7). Vasoreparative function of CACs was assessed by migration ability toward CXCL12 (SDF-1) using QCM 5μM 96-well chemotaxis cell migration assay.

Results : By VESGEN analysis, vessel density measured by Lv, Av, and Nv in early NPDR was greater than in control. For example, Lv was 2.00±0.06E-2 px/px2 in NPDR veins for all branching generations compared to 1.01±0.06E-2 px/px2 in control, and 1.64±0.13E-2 px/px2 compared to 8.90±1.37E-3 px/px2 in arteries. Results were confirmed by other parameters such as Av and Nv. The expression of Mas in CACs was reduced in NPDR relative to control, indicating possible loss of compensation of the protective RAS at this stage of DR. NPDR was associated with CD34+ CAC migratory dysfunction toward CXCL12, which was corrected with Ang-(1-7) pretreatment prior to CXCL12 exposure.

Conclusions : For our ongoing longitudinal study, preliminary evidence by VESGEN indicates that vascular density increased in early NPDR compared to control. If confirmed by more complete analysis, results are potentially of value for determining optimal therapies at early stages of NPDR, when regenerative vascular treatments are more likely to be successful. These data also suggest the protective RAS axis within diabetic CACs is lost early in DR and is associated with increased vascular remodeling evidenced by VESGEN analysis.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×